Pricing

Cyteir Therapeutics Inc (CYT)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Markus F. Renschler
Employees:
40
99 HAYDEN AVENUE, BUILDING B, SUITE 450, LEXINGTON, MA, 02421
857-285-4140

Are you looking for this stock instead?

Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851 is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies. The company was incorporated in 2012 and is based in Lexington, Massachusetts.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available